Genmab reported 356M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.28M 0.28M
AstraZeneca AZN:LN 28888M 51M
Bayer BAYN:GR € 36481M 493M
Galapagos GLPG:NA 19.65M 527K
Genmab GEN:DC 356M 7M
GRIFOLS GRF:SM € 6978M 247.04M
Hikma Pharmaceutical HIK:LN 725M 26M
Lonza Group LONN:SW 2.23B 555M
Novartis NOVN:VX SF 24523M 192M
William Demant Holding WDH:DC 4.4B 557M